Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial - Quiz - MDSpire

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • By

  • Mark J Bolland

  • Zaynah Nisa

  • Anna Mellar

  • Chiara Gasteiger

  • Veronica Pinel

  • Borislav Mihov

  • Sonja Bastin

  • Andrew Grey

  • Ian R Reid

  • Greg Gamble

  • Anne Horne

  • October 18, 2025

  • 0 min

Share

Original Source(s)

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • by Mark J Bolland, Zaynah Nisa, Anna Mellar, Chiara Gasteiger, Veronica Pinel, Borislav Mihov, Sonja Bastin, Andrew Grey, Ian R Reid, Greg Gamble, Anne Horne

  • October 18, 2025

Related Content

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis

Beyond resorption-driven coupling: a multi-layered framework for osteoclast–osteoblast communication and its therapeutic consequences

The mechanism of action and therapeutic potential of macrophages in osteoporosis: from polarization balance to targeted regulation